FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 212 filers reported holding FIBROGEN INC in Q3 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $178,886 | -79.3% | 66,254 | +42.9% | 0.01% | -81.1% |
| Q1 2023 | $865,190 | +91.0% | 46,366 | +172.8% | 0.05% | +253.3% |
| Q2 2021 | $453,000 | -24.6% | 16,994 | -1.9% | 0.02% | -34.8% |
| Q1 2021 | $601,000 | -14.0% | 17,328 | -8.1% | 0.02% | -25.8% |
| Q4 2020 | $699,000 | +0.3% | 18,858 | +11.2% | 0.03% | -13.9% |
| Q3 2020 | $697,000 | -10.2% | 16,956 | -11.5% | 0.04% | -16.3% |
| Q2 2020 | $776,000 | +38.8% | 19,151 | +19.0% | 0.04% | +2.4% |
| Q1 2020 | $559,000 | -42.8% | 16,088 | -29.4% | 0.04% | -2.3% |
| Q4 2019 | $977,000 | +33.1% | 22,772 | +14.7% | 0.04% | +16.2% |
| Q3 2019 | $734,000 | -20.6% | 19,848 | -3.1% | 0.04% | -15.9% |
| Q2 2019 | $925,000 | -23.6% | 20,484 | -8.0% | 0.04% | -24.1% |
| Q1 2019 | $1,210,000 | +17.7% | 22,261 | +0.2% | 0.06% | -9.4% |
| Q4 2018 | $1,028,000 | -38.8% | 22,209 | -19.6% | 0.06% | 0.0% |
| Q3 2018 | $1,679,000 | – | 27,632 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $7,880,000 | 4.60% |
| ARMISTICE CAPITAL, LLC | 4,456,000 | $57,973,000 | 1.01% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $2,489,000 | 0.78% |
| BHK Investment Advisors, LLC | 87,450 | $1,138,000 | 0.57% |
| Soleus Capital Management, L.P. | 234,026 | $3,045,000 | 0.41% |
| Tri Locum Partners LP | 74,348 | $967,000 | 0.26% |
| Point72 Asset Management, L.P. | 4,777,700 | $62,158,000 | 0.25% |
| PRIMECAP MANAGEMENT CO/CA/ | 13,179,897 | $171,470,000 | 0.17% |
| Newbridge Financial Services Group, Inc. | 20,285 | $264,000 | 0.16% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,430,526 | $18,611,000 | 0.15% |